OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001499785

Tengjun Biotechnology Corp.

Tengjun Biotechnology Corp. (CIK 0001499785, EIN 27-3042462) reported revenue of $150.14 million ($150,136,738) for FY2022 (2022-01-01 to 2022-12-31) and net income of $11.35 million ($11,346,841) for FY2022 (2022-01-01 to 2022-12-31), as filed in its 10-K filed 2023-04-17 (accession 0001213900-23-030342).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001499785
EIN27-3042462
SIC industry code2080 Beverages
State or country of incorporationNV
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_260nc7mz3vm4mp53568ecmc0xt
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$150,136,738FY20222022-01-01 to 2022-12-3110-K2023-04-170001213900-23-030342Revenues
Net income$11,346,841FY20222022-01-01 to 2022-12-3110-K2023-04-170001213900-23-030342NetIncomeLoss
Total assets$58,629,500FY2022as of 2022-12-3110-K2023-04-170001213900-23-030342Assets
Total liabilities$43,656,963FY2022as of 2022-12-3110-K2023-04-170001213900-23-030342Liabilities
Stockholders' equity$14,455,397FY2022as of 2022-12-3110-K2023-04-170001213900-23-030342StockholdersEquity
Operating cash flow$1,347,451FY20222022-01-01 to 2022-12-3110-K2023-04-170001213900-23-030342NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$0 per shareFY20202020-01-01 to 2020-12-3110-K2021-02-170001213900-21-010139EarningsPerShareBasicAndDiluted
Shares outstanding99,309,169 sharesFY2022as of 2023-03-3110-K2023-04-170001213900-23-030342EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222022-01-01 to 2022-12-31$150,136,73810-K2023-04-170001213900-23-030342
RevenueFY20202020-01-01 to 2020-12-31$29010-K2022-03-310001213900-22-016671
Net incomeFY20222022-01-01 to 2022-12-31$11,346,84110-K2023-04-170001213900-23-030342
Net incomeFY20212021-01-01 to 2021-12-31-$747,52510-K2023-04-170001213900-23-030342
Net incomeFY20202020-01-01 to 2020-12-31-$690,88610-K2022-03-310001213900-22-016671
Net incomeFY20192019-01-01 to 2019-12-31-$59,86510-K2021-02-170001213900-21-010139
Net incomeFY20182018-01-01 to 2018-12-31-$47,80610-K2020-02-280001213900-20-005061
Net incomeFY20172017-01-01 to 2017-12-31-$48,23110-K2019-03-080001213900-19-003819
Net incomeFY20162016-01-01 to 2016-12-31-$60,66410-K2018-03-070001213900-18-002641
Net incomeFY20152015-01-01 to 2015-12-31-$74,70910-K2017-03-270001213900-17-002815
Net incomeFY20142014-01-01 to 2014-12-31-$108,36410-K2016-03-300001213900-16-012067
Net incomeFY20132013-01-01 to 2013-12-31-$21,31410-K2015-04-140001213900-15-002672
  • Net income for FY2020 was restated: first reported as -$53,868 (accession 0001213900-21-010139, filed 2021-02-17).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2023-08-152023-06-300001213900-23-067340f10q0623_tengjunbio.htm
10-Q2023-05-152023-03-310001213900-23-039845f10q0323_tengjunbio.htm
10-K2023-04-172022-12-310001213900-23-030342f10k2022_tengjunbio.htm
10-Q2022-11-142022-09-300001213900-22-071678f10q0922_tengjunbio.htm
10-Q/A2022-09-162022-06-300001213900-22-056649f10q0622a1_tengjunbio.htm
10-Q2022-08-152022-06-300001213900-22-048155f10q0622_tengjunbiotech.htm
10-Q2022-05-132022-03-310001213900-22-026587f10q0322_tengjunbiotech.htm
10-K2022-03-312021-12-310001213900-22-016671f10k2021_tengjunbio.htm
10-Q2021-10-202021-09-300001213900-21-053733f10q0921_tengjunbiotech.htm
10-Q2021-07-202021-06-300001213900-21-037645f10q0621_tengjunbio.htm
10-Q2021-04-162021-03-310001213900-21-021813f10q0321_tengjunbiotech.htm
10-K2021-02-172020-12-310001213900-21-010139f10k2020_tengjunbiotech.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001499785published by the sourcedata.sec.gov/submissions/CIK0001499785.json2026-10-21
Employer Identification Number (EIN) · US-EIN27-3042462published by the sourcedata.sec.gov/submissions/CIK0001499785.json2026-10-21

Former names

NameFromTo
China Herb Group Holdings Corp2012-07-262019-10-25
Island Radio, Inc.2010-09-162012-07-17

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001499785.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001499785.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001499785" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001499785/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001499785/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1499785"}

On SEC EDGAR

About this data